v3.22.4
BUSINESS COMBINATIONS - ApiFix Narrative (Details)
12 Months Ended
Apr. 01, 2020
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
Business Acquisition        
Common stock, par value (in dollars per share) | $ / shares   $ 0.00025 $ 0.00025  
Fair value adjustment of contingent consideration   $ (25,930,000) $ (1,800,000) $ 3,520,000
Contingent consideration, accretion expense   $ 2,307,000 $ 2,155,000 $ 2,397,000
ApiFix        
Business Acquisition        
Cash consideration $ 2,000,000      
Cash acquired $ 344,000      
Consideration for acquisition (in shares) | shares 934,783      
Common stock, par value (in dollars per share) | $ / shares $ 0.00025      
Issuance of common stock $ 35,176,000      
Common stock (in dollars per share) | $ / shares $ 37.63      
Anniversary payments $ 30,000,000      
System sales payment 41,741,000      
Fair value of total acquisition consideration 87,379,000      
Acquisition related costs $ 311,000      
Number of clinical procedures (procedure) 150      
Revenue multiplier 2.25      
Minimum percentage of contingent consideration payable in cash 25.00%      
Percentage on contingent consideration that can be settled in shares 75.00%      
ApiFix | Second Anniversary        
Business Acquisition        
Anniversary payments $ 13,000      
ApiFix | Third Anniversary        
Business Acquisition        
Anniversary payments 8,000      
ApiFix | Fourth Anniversary        
Business Acquisition        
Anniversary payments $ 9,000